1.
|
Claas C, Herrmann K, Matzku S, Möller P
and Zöller M: Developmentally regulated expression of
metastasis-associated antigens in the rat. Cell Growth Differ.
7:663–678. 1996.PubMed/NCBI
|
2.
|
Matzku S, Wenzel A, Liu S and Zöller M:
Antigenic differences between metastatic and nonmetastatic BSp73
rat tumor variants characterized by monoclonal antibodies. Cancer
Res. 49:1294–1299. 1989.PubMed/NCBI
|
3.
|
Würfel J, Seiter S, Stassar M, et al:
Cloning of the human homologue of the metastasis-associated rat
C4.4A. Gene. 262:35–41. 2001.PubMed/NCBI
|
4.
|
Rösel M, Claas C, Seiter S, Herlevsen M
and Zöller M: Cloning and functional characterization of a new
phosphatidyl-inositol anchored molecule of a metastasizing rat
pancreatic tumor. Oncogene. 17:1989–2002. 1998.PubMed/NCBI
|
5.
|
Hansen LV, Gårdsvoll H, Nielsen BS, et al:
Structural analysis and tissue localization of human C4.4A: a
protein homologue of the urokinase receptor. Biochem J.
380:845–857. 2004. View Article : Google Scholar : PubMed/NCBI
|
6.
|
Hansen LV, Skov BG, Ploug M and Pappot H:
Tumour cell expression of C4.4A, a structural homologue of the
urokinase receptor, correlates with poor prognosis in non-small
cell lung cancer. Lung Cancer. 58:260–266. 2007. View Article : Google Scholar : PubMed/NCBI
|
7.
|
Seiter S, Stassar M, Rappl G, Reinhold U,
Tilgen W and Zöller M: Upregulation of C4.4A expression during
progression of melanoma. J Invest Dermatol. 116:344–347. 2001.
View Article : Google Scholar
|
8.
|
Fletcher G, Patel S, Tyson K, et al: hAG-2
and hAG-3, human homologues of genes involved in differentiation,
are associated with oestrogen receptor-positive breast tumours and
interact with metastasis gene C4.4a and dystroglycan. Br J Cancer.
88:579–585. 2003. View Article : Google Scholar : PubMed/NCBI
|
9.
|
Paret C, Hildebrand D, Weitz J, et al:
C4.4A as a candidate marker in the diagnosis of colorectal cancer.
Br J Cancer. 97:1146–1156. 2007. View Article : Google Scholar : PubMed/NCBI
|
10.
|
Smith BA, Kennedy WJ, Harnden P, Selby PJ,
Trejdosiewicz LK and Southgate J: Identification of genes involved
in human urothelial cell - matrix interactions: implications for
the progression pathways of malignant urothelium. Cancer Res.
61:1678–1685. 2001.PubMed/NCBI
|
11.
|
Konishi K, Yamamoto H, Mimori K, et al:
Expression of C4.4A at the invasive front is a novel prognostic
marker for disease recurrence of colorectal cancer. Cancer Sci.
101:2269–2277. 2010. View Article : Google Scholar : PubMed/NCBI
|
12.
|
Noura S, Yamamoto H, Ohnishi T, et al:
Comparative detection of lymph node micrometastases of stage II
colorectal cancer by reverse transcriptase polymerase chain
reaction and immunohistochemistry. J Clin Oncol. 20:4232–4241.
2002. View Article : Google Scholar
|
13.
|
Yamamoto H, Kondo M, Nakamori S, et al:
JTE-522, a cyclooxygenase-2 inhibitor, is an effective
chemopreventive agent against rat experimental liver fibrosis.
Gastroenterology. 125:556–571. 2003.PubMed/NCBI
|
14.
|
Takemasa I, Yamamoto H, Sekimoto M, et al:
Overexpression of CDC25B phosphatase as a novel marker of poor
prognosis of human colorectal carcinoma. Cancer Res. 60:3043–3050.
2000.PubMed/NCBI
|
15.
|
Yamamoto H, Soh JW, Shirin H, et al:
Comparative effects of overexpression of p27Kip1 and
p21Cip1/Waf1 on growth and differentiation in human
colon carcinoma cells. Oncogene. 18:103–115. 1999.
|
16.
|
Hansen LV, Laerum OD, Illemann M, Nielsen
BS and Ploug M: Altered expression of the urokinase receptor
homologue, C4.4A, in invasive areas of human esophageal squamous
cell carcinoma. Int J Cancer. 122:734–741. 2008. View Article : Google Scholar : PubMed/NCBI
|
17.
|
Oshiro R, Yamamoto H, Takahashi H, et al:
C4.4A is associated with tumor budding and epithelial-mesenchymal
transition of colorectal cancer. Cancer Sci. 103:1155–1164. 2012.
View Article : Google Scholar : PubMed/NCBI
|
18.
|
Hase K, Shatney C, Johnson D, Trollope M
and Vierra M: Prognostic value of tumor budding in patients with
colorectal cancer. Dis Colon Rectum. 36:627–635. 1993. View Article : Google Scholar : PubMed/NCBI
|
19.
|
Ueno H, Murphy J, Jass J, Mochizuki H and
Talbot I: Tumour-budding as an index to estimate the potential of
aggressiveness in rectal cancer. Histopathology. 40:127–132. 2002.
View Article : Google Scholar : PubMed/NCBI
|